These D.C.-area biotech companies are making progress on COVID-19. Here's the latest.

Washington Business Journal

Apr 3, 2020

Greater Washington's companies aren't letting up in their work against the novel coronavirus. Some, from public biotechs like Novavax Inc. (NASDAQ: NVAX) to aspiring public biotech…